Literature DB >> 3426606

The major erythrotropin of bovine Cohn fraction V has the N-terminal sequence of insulin-like growth factor II with isoleucine at position 35.

L F Congote1, F Esch.   

Abstract

The major erythrotropin-like factor of bovine Cohn Fraction V has been isolated from commercial albumin preparations by reversed-phase HPLC. The N-terminal sequence of the major fraction with erythrotropin-like activity is practically identical to the sequence of bovine insulin-like growth factor II. Within the first 45 amino acids, the only difference was the presence of an isoleucine instead of a serine at amino acid 35. This substitution may affect the immunoreactivity of this peptide using antibodies against bovine or human insulin-like growth factor II.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3426606     DOI: 10.1016/0006-291x(87)90511-0

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Serum Cohn fraction IV-1 supports the growth of Giardia lamblia in vitro.

Authors:  H D Lujan; L G Byrd; M R Mowatt; T E Nash
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

2.  Isolation from fetal bovine serum of an apolipoprotein-H-like protein which inhibits thymidine incorporation in fetal calf erythroid cells.

Authors:  Q G Li; R Blacher; F Esch; L F Congote
Journal:  Biochem J       Date:  1990-04-01       Impact factor: 3.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.